Public Board of Directors papers 27-10-22

5. To provide leadership within the local network of cancer care Annual objective

Measure

Timescale

Director

Progress

5.1 Implement the GM surgical oncology Strategy 5.2 Refresh of chemotherapy delivery strategy

Sustain Mutual Aid for GM to meet system recovery plans

31.3.23

COO

On plan

31.3.23

COO

On plan

Align localisation of chemotherapy with the refreshed strategy Development of governance arrangements for delivery of trials at the outreach centres Develop Haematology Strategy in line with Manchester Cancer plans Develop further the role of the ODN in future commissioning models Support Radiotherapy service resilience across the North West.

31.3.23

COO

On plan

5.3 Development of Haematology strategy

31.3.23

COO

On plan

5.4 Implement Radiotherapy Strategy

31.3.23

COO

On plan

31.3.23

COO

On plan

5.5 Delivery of National PET Service

31.3.23 31.3.23

COO COO Exec Team

On plan On plan

Embed PET service provision into ICS

Sustain PET CT services to GM in line with the NC2 contract Implementation of the Cancer operating model within the ICS

5.6 Cancer System leadership

On plan

31.3.23

6. To maintain excellent operational, quality and financial performance Annual objective

Measure

Timescale

Director

Progress

Maintain a rating of 1 within the finance and use of resources oversight theme as part of the NHS System Oversight Framework Delivery of Trust profit share in line with the financial plan for TCPC and CPP Agreement of 22/23 commissioner contract with NHSE and GM ICS which secures resource against planned activity. Work with the GM ICS in order to agree a fair and equitable allocation of the capital and revenue resources available to the system to deliver recovery and restoration of activity.

6.1 To develop and deliver our financial strategy

31.3.23

EDoF

Delivering to plan

31.3.23

EDoF

On plan

6.2 Continue to improve relationships with commissioners

31.3.23

EDoF

On plan

31.3.23

EDoF

On plan

22